RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Dr Reddy's Laboratories Stock

Dr Reddy's Laboratories Equity 2024

Dr Reddy's Laboratories Equity

282.55 B INR

Ticker

DRREDDY.NS

ISIN

INE089A01023

WKN

659157

In 2024, Dr Reddy's Laboratories's equity was 282.55 B INR, a 47.07% increase from the 192.12 B INR equity in the previous year.

Dr Reddy's Laboratories Aktienanalyse

What does Dr Reddy's Laboratories do?

Dr. Reddy's Laboratories Ltd is an Indian pharmaceutical company that was founded in 1984 by Dr. K. Anji Reddy. The company started as a small laboratory in Hyderabad, India and quickly grew to become one of the leading global pharmaceutical companies. History The company began as a chemical research institute specializing in the development of high-quality generics and new drugs. Dr. Reddy's Laboratories was one of the first companies in India to begin manufacturing and exporting generics on a large scale. Today, the company operates in over 100 countries worldwide and employs over 21,000 people. Business Model The company's business model focuses on developing high-quality and affordable medications to improve the lives of patients worldwide. The company invests millions of dollars annually in research and development of new drugs to provide people with innovative and better treatment options. Various Divisions Dr. Reddy's Laboratories is divided into several business divisions, including: - Generics: A key business factor is generic production, including various dosages and forms of oral solid or liquid medications. - Biosimilars: Dr. Reddy's Laboratories has several biosimilars in its portfolio, including Epoetin alfa, Darbepoetin alfa, and Pegfilgastim, used for treating various diseases and conditions. - Specialty Products: The company also offers a variety of specialty products, particularly in the field of oncology. Products Over the years, Dr. Reddy's Laboratories has developed many innovative, high-quality, and affordable medications. Some of the company's most well-known products include: - Omez: A popular gastric medication used to treat heartburn and reflux. - Norflox: An antibiotic used to treat bacterial infections. - Reditux: A biosimilar of the antibody Rituximab used in cancer treatment. - Librium: A medication used for anxiety and depression. Conclusion Dr. Reddy's Laboratories is a global company specializing in the research, development, and manufacturing of innovative, high-quality, and affordable medications. The company has a long history in generic production and the manufacturing of specialty products and biosimilars. Through its research and development programs, the company constantly strives to meet the needs of patients and provide them with better healthcare. Dr Reddy's Laboratories ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Dr Reddy's Laboratories's Equity

Dr Reddy's Laboratories's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Dr Reddy's Laboratories's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Dr Reddy's Laboratories's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Dr Reddy's Laboratories's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Dr Reddy's Laboratories’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Dr Reddy's Laboratories stock

What is the equity of Dr Reddy's Laboratories this year?

Dr Reddy's Laboratories has equity of 282.55 B INR this year.

What was the equity of Dr Reddy's Laboratories compared to the previous year?

The equity of Dr Reddy's Laboratories has increased/decreased by 47.07% increased compared to the previous year.

What impact does a high equity have on investors of Dr Reddy's Laboratories?

A high equity is advantageous for investors of Dr Reddy's Laboratories as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Dr Reddy's Laboratories?

A low equity can be a risk for investors of Dr Reddy's Laboratories, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Dr Reddy's Laboratories affect the company?

An increase in equity of Dr Reddy's Laboratories can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Dr Reddy's Laboratories affect the company?

A reduction in equity of Dr Reddy's Laboratories can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Dr Reddy's Laboratories?

Some factors that can affect the equity of Dr Reddy's Laboratories include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Dr Reddy's Laboratories so important for investors?

The equity of Dr Reddy's Laboratories is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Dr Reddy's Laboratories take to change the equity?

To change equity, Dr Reddy's Laboratories can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Dr Reddy's Laboratories pay?

Over the past 12 months, Dr Reddy's Laboratories paid a dividend of 40 INR . This corresponds to a dividend yield of about 0.59 %. For the coming 12 months, Dr Reddy's Laboratories is expected to pay a dividend of 43.54 INR.

What is the dividend yield of Dr Reddy's Laboratories?

The current dividend yield of Dr Reddy's Laboratories is 0.59 %.

When does Dr Reddy's Laboratories pay dividends?

Dr Reddy's Laboratories pays a quarterly dividend. This is distributed in the months of August, August, August, August.

How secure is the dividend of Dr Reddy's Laboratories?

Dr Reddy's Laboratories paid dividends every year for the past 0 years.

What is the dividend of Dr Reddy's Laboratories?

For the upcoming 12 months, dividends amounting to 43.54 INR are expected. This corresponds to a dividend yield of 0.65 %.

In which sector is Dr Reddy's Laboratories located?

Dr Reddy's Laboratories is assigned to the 'Health' sector.

Wann musste ich die Aktien von Dr Reddy's Laboratories kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Dr Reddy's Laboratories from 8/28/2024 amounting to 40 INR, you needed to have the stock in your portfolio before the ex-date on 7/16/2024.

When did Dr Reddy's Laboratories pay the last dividend?

The last dividend was paid out on 8/28/2024.

What was the dividend of Dr Reddy's Laboratories in the year 2023?

In the year 2023, Dr Reddy's Laboratories distributed 40 INR as dividends.

In which currency does Dr Reddy's Laboratories pay out the dividend?

The dividends of Dr Reddy's Laboratories are distributed in INR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Dr Reddy's Laboratories

Our stock analysis for Dr Reddy's Laboratories Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Dr Reddy's Laboratories Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.